Zobrazeno 1 - 10
of 176
pro vyhledávání: '"Russell Z Szmulewitz"'
Autor:
Daniel Huang, Connor Lynch, Lucas M. Serra, Randy F. Sweis, Paul J. Chang, Walter M. Stadler, Russell Z. Szmulewitz, Peter H. O’Donnell, Abhinav Sidana, Scott E. Eggener, Arieh L. Shalhav, Stanley L. Liauw, Sean P. Pitroda
Publikováno v:
Clinical and Translational Radiation Oncology, Vol 49, Iss , Pp 100879- (2024)
Background and purpose: Stereotactic ablative body radiotherapy (SABR) is an effective treatment for localized renal cell carcinoma (RCC). However, the role of primary site SABR for locally recurrent or metastatic RCC is unclear. Here, we report outc
Externí odkaz:
https://doaj.org/article/1a67d80417974116897b0aff6bb0ac82
Publikováno v:
Indian Journal of Urology, Vol 26, Iss 1, Pp 92-97 (2010)
Introduction/Methods : Approximately 30% of nonseminomatous germ-cell tumors (NSGCT) of the testis present with metastatic disease. In 1997, the International Germ Cell Cancer Collaborative Group (IGCCCG) stratified all patients with metastatic NSGCT
Externí odkaz:
https://doaj.org/article/bb985a2915254551baf568feb2a9a4d0
Publikováno v:
Frontiers in Oncology, Vol 5 (2015)
Solid tumors harboring BRCA1 or BRCA2 mutations have been shown to respond to PARP inhibitors. These responses are partial and transient. In this case report we describe an 80-yr old male with poorly differentiated prostate cancer with metastases to
Externí odkaz:
https://doaj.org/article/4a5d0f7fef1f41158473d655e9d5d218
Autor:
Steven Kregel, Kyle J Kiriluk, Alex M Rosen, Yi Cai, Edwin E Reyes, Kristen B Otto, Westin Tom, Gladell P Paner, Russell Z Szmulewitz, Donald J Vander Griend
Publikováno v:
PLoS ONE, Vol 8, Iss 1, p e53701 (2013)
Despite advances in detection and therapy, castration-resistant prostate cancer continues to be a major clinical problem. The aberrant activity of stem cell pathways, and their regulation by the Androgen Receptor (AR), has the potential to provide in
Externí odkaz:
https://doaj.org/article/ddac220b1ff448a2ba7b4a794360b2c0
Autor:
Jason P. Meier, Hannah J. Zhang, Richard Freifelder, Mohammed Bhuiyan, Phillip Selman, Megan Mendez, Pavithra H. A. Kankanamalage, Thomas Brossard, Antonino Pusateri, Hsiu-Ming Tsai, Lara Leoni, Sagada Penano, Kaustab Ghosh, Brittany A. Broder, Erica Markiewicz, Amy Renne, Walter Stadler, Ralph Weichselbaum, Jerry Nolen, Chien-Min Kao, Satish K. Chitneni, David A. Rotsch, Russell Z. Szmulewitz, Chin-Tu Chen
Publikováno v:
Molecules, Vol 28, Iss 16, p 6041 (2023)
In the field of nuclear medicine, the β+ -emitting 43Sc and β− -emitting 47Sc are promising candidates in cancer diagnosis and targeted radionuclide therapy (TRT) due to their favorable decay schema and shared pharmacokinetics as a true theranost
Externí odkaz:
https://doaj.org/article/d2d85dab6fef4b49ba4943ebf7d7c673
Autor:
Santosh Gupta, Susan Halabi, Qian Yang, Akash Roy, Alisa Tubbs, Yamini Gore, Daniel J. George, David M. Nanus, Emmanuel S. Antonarakis, Daniel C. Danila, Russell Z. Szmulewitz, Richard Wenstrup, Andrew J. Armstrong
Publikováno v:
Clin Cancer Res
Purpose: In men with metastatic castration-resistant prostate cancer (mCRPC), prostate-specific membrane antigen (PSMA)-targeted radioligand therapy has drastically improved clinical outcomes. A liquid biopsy characterizing PSMA expression could be u
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cbe34ca4227c1aef0aa2de4fe2c4a0e6
https://doi.org/10.1158/1078-0432.ccr-22-3233
https://doi.org/10.1158/1078-0432.ccr-22-3233
Autor:
Andrew J. Armstrong, Richard Wenstrup, Russell Z. Szmulewitz, Daniel C. Danila, Emmanuel S. Antonarakis, David M. Nanus, Daniel J. George, Yamini Gore, Alisa Tubbs, Akash Roy, Qian Yang, Susan Halabi, Santosh Gupta
Purpose:In men with metastatic castration-resistant prostate cancer (mCRPC), prostate-specific membrane antigen (PSMA)-targeted radioligand therapy has drastically improved clinical outcomes. A liquid biopsy characterizing PSMA expression could be us
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::81f914b45abf1914bd608195292c6d30
https://doi.org/10.1158/1078-0432.c.6516198.v4
https://doi.org/10.1158/1078-0432.c.6516198.v4
Autor:
Andrew J. Armstrong, Richard Wenstrup, Russell Z. Szmulewitz, Daniel C. Danila, Emmanuel S. Antonarakis, David M. Nanus, Daniel J. George, Yamini Gore, Alisa Tubbs, Akash Roy, Qian Yang, Susan Halabi, Santosh Gupta
CTC biomarker group incidence by PSMA optimal cutoff (AR-v7, chromosomal instability (CIN), and neuroendocrine (NE) at baseline (N=97) and progression (N=57).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3e66639d28b0e9f542671badbfd82151
https://doi.org/10.1158/1078-0432.22820158.v1
https://doi.org/10.1158/1078-0432.22820158.v1
Autor:
Andrew J. Armstrong, Taro Iguchi, Arun A. Azad, Arnauld Villers, Boris Alekseev, Daniel P. Petrylak, Russell Z. Szmulewitz, Antonio Alcaraz, Neal D. Shore, Jeffrey Holzbeierlein, Francisco Gomez-Veiga, Brad Rosbrook, Fabian Zohren, Gabriel P. Haas, Georgia Gourgiotti, Nader El-Chaar, Arnulf Stenzl
Publikováno v:
European Urology.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7a3a411f6408ec82d9e9661a21d283f2
https://doi.org/10.1016/j.eururo.2023.04.002
https://doi.org/10.1016/j.eururo.2023.04.002
Autor:
Andrew J. Armstrong, Richard Wenstrup, Russell Z. Szmulewitz, Daniel C. Danila, Emmanuel S. Antonarakis, David M. Nanus, Daniel J. George, Yamini Gore, Alisa Tubbs, Akash Roy, Qian Yang, Susan Halabi, Santosh Gupta
PSMA protein expression distribution from men with mCRPC at a single cell CTC level before (baseline, N= 97) and after (progression, N= 57) abiraterone or enzalutamide therapy.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3d505e4e14ab7c24090448bcf264b1ae
https://doi.org/10.1158/1078-0432.22596027.v1
https://doi.org/10.1158/1078-0432.22596027.v1